According to Ionis Pharmaceuticals 's latest financial reports the company's current earnings are โน0.70 Billion. a decrease over its 2023 earnings that were of -โน22.03 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -โน32.07 Billion | 45.63% |
2023 | -โน22.03 Billion | 0.71% |
2022 | -โน21.87 Billion | 793.58% |
2021 | -โน2.45 Billion | -77.29% |
2020 | -โน10.78 Billion | -131.79% |
2019 | โน33.89 B | -1361.08% |
2018 | -โน2.69 Billion | -196.52% |
2017 | โน2.78 B | -172.49% |
2016 | -โน3.85 Billion | -12.4% |
2015 | -โน4.39 Billion | 59.02% |
2014 | -โน2.76 Billion | -31.83% |
2013 | -โน4.05 Billion | -11.66% |
2012 | -โน4.58 Billion | -21.48% |
2011 | -โน5.84 Billion | 42% |
2010 | -โน4.11 Billion | 151.02% |
2009 | -โน1.64 Billion | |
2007 | -โน3.34 Billion | -43.27% |
2006 | -โน5.89 Billion | 36.7% |
2005 | -โน4.31 Billion | -41.21% |
2004 | -โน7.33 Billion | 10.69% |
2003 | -โน6.62 Billion | 56.1% |
2002 | -โน4.24 Billion | 7.24% |
2001 | -โน3.96 Billion | 59.03% |
2000 | -โน2.49 Billion | -32.74% |
1999 | -โน3.7 Billion | 31.8% |
1998 | -โน2.81 Billion | 3.15% |
1997 | -โน2.72 Billion | 8.19% |
1996 | -โน2.52 Billion | 14.01% |
1995 | -โน2.21 Billion | 0.78% |
1994 | -โน2.19 Billion | 37.84% |
1993 | -โน1.59 Billion | -13.95% |
1992 | -โน1.85 Billion | 95.45% |
1991 | -โน0.95 Billion | 144.44% |
1990 | -โน0.39 Billion |